Mitchell P. Kopin 13D/13G Filings for Plus Therapeutics, Inc. (PSTV)

Mitchell P. Kopin 13D and 13G filings for Plus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
07:53 am
Unchanged		 2021-12-31 13G Plus Therapeutics, Inc.
PSTV		 Mitchell P. Kopin 20,000
1.900%		 0
(Unchanged)		 Filing
2021-01-29
06:54 am
Sale		 2020-12-31 13G Plus Therapeutics, Inc.
PSTV		 Mitchell P. Kopin 20,000
5.900%		 -7,039decrease
(-26.03%)		 Filing